# GRADIENT MEDICAL, INC.: Commercialization of Algorithmic Non-thermal Ablation Technology for the Treatment of Inoperable Tumors

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | GRADIENT MEDICAL, INC. |
| Location | Raleigh, NC |
| Project | Commercialization of Algorithmic Non-thermal Ablation Technology for the Treatment of Inoperable Tumors |
| Project number | 5R42CA275587-03 |
| Mechanism | R42 |
| Institute | National Cancer Institute |
| Award | $1,150,000 |
| Awarded | 2026-09-17 |
| Project period | 2022-09-16 to 2027-08-31 |
| UEI | HPZ7FS9MF8J1 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11411434). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.